Neurotoxicity caused by impaired TTBK2 kinase activity against known neuronal targets, such as tau, TDP-43, neurotransmitter receptors or transporters, may contribute to neurodegeneration in SCA11. The gene discussed is TARDBP; the disease is spinocerebellar ataxia type 11.